Maria Dolores
Chirlaque Lopez
Asociado a Tiempo Parcial
![Foto de Maria Dolores](/img/uploaded/b556d6d2a9b2447a5d110cb58611f508.jpeg)
![Foto de New York University School of Medicine](/img/noimage_org.png)
New York University School of Medicine
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de New York University School of Medicine (10)
2020
-
Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12
2019
-
Discovery of common and rare genetic risk variants for colorectal cancer
Nature Genetics, Vol. 51, Núm. 1, pp. 76-87
2018
2017
-
Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort
International Journal of Cancer, Vol. 140, Núm. 6, pp. 1246-1259
2015
-
Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Breast Cancer Research and Treatment, Vol. 154, Núm. 2, pp. 389-401
2013
-
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
Nature Genetics, Vol. 45, Núm. 8, pp. 868-876
2010
-
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies
The Lancet Oncology, Vol. 11, Núm. 6, pp. 530-542
-
Obesity, inflammatory markers, and endometrial cancer risk: A prospective case - control study
Endocrine-Related Cancer, Vol. 17, Núm. 4, pp. 1007-1019
2006
-
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort
International Journal of Cancer, Vol. 118, Núm. 11, pp. 2832-2839
-
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
Endocrine-Related Cancer, Vol. 13, Núm. 2, pp. 593-605